A new online platform ShareIn is connecting biotech companies with investors. This is forcing traditional funders to up their game and cut back on layers of intermediary costs for start-ups, says Jude Cook, co-founder of ShareIn
Digital technologies can help older adults maintain independence and assist with their care. But resistance to change and a shortage of objective data to help communicate its value, is making it hard to commercialise products and build markets, says Martijn Vastenburg
A new EU data protection law risks killing some types of medical research, researchers at the Karolinska Institutet say. Their prescription: A law that regulates Big Data, but allows for research
InSphero’s breakthrough in generating 3D cell models of human organs at scale for use in toxicity screens attracted potential customers to invest in proving the technology. Now all the top ten pharma companies are users
Biologic drugs deliver health and wealth. But it is a long, fraught path from lab to bedside. Science|Business brought together research, business and policymakers to draft a risk-reduction plan for the new Parliament and Commission
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.